+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

  • ID: 4752352
  • Report
  • Region: Global
  • 118 pages
  • IMARC Group
1 of 3

FEATURED COMPANIES

  • Akorn Inc.
  • Alimera Science
  • Allergan plc.
  • Auven Therapeutics
  • Bausch + Lomb
  • GlaxoSmithKline plc.
  • MORE
The global dry eye syndrome market was worth US$ 3.5 Billion in 2018. Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person's eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer use, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

Various diseases, such as diabetes, thyroid disorders, Sjogren's syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient's blood which adversely affects the tear glands resulting in a rising prevalence of dry eye. Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being fairly high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc. Looking forward, the market value is projected to reach US$ 5.1 Billion by 2024, exhibiting a CAGR of 6.5% during 2019-2024.

Market Summary:

Based on the disease type, the market has been segmented into evaporative dry eye syndrome and aqueous dry eye syndrome.

Based on the drug type, the market has been segmented into lubricant eye drops, anti-inflammatory drugs and autologous serum eye drops.

Based on the product type, the market has been segmented into liquid drops, gel, liquid wipes, eye ointment and others.

Based on the distribution channels, the market has been segmented into retail pharmacies, hospital pharmacies and online pharmacies.

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

The competitive landscape of the market has also been examined with some of the key players being Novartis AG, Allergan plc., Otsuka Holdings Co., Ltd., Santen Pharmaceutical Co., Ltd., Nicox S.A., Auven Therapeutics, Akorn, Inc., Bausch + Lomb, Alimera Science and GlaxoSmithKline plc.

This report provides a deep insight into the global dry eye syndrome market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the dry eye syndrome market in any manner.

Key Questions Answered in This Report:
  • How has the global dry eye syndrome market performed so far and how will it perform in the coming years?
  • What is the breakup of the global dry eye syndrome market on the basis of region?
  • What is the breakup of the global dry eye syndrome market on the basis of disease type?
  • What is the breakup of the global dry eye syndrome market on the basis of drug type?
  • What is the breakup of the global dry eye syndrome market on the basis of product type?
  • What is the breakup of the global dry eye syndrome market on the basis of distribution channel?
  • What are the various stages in the value chain of the global dry eye syndrome market?
  • What are the key driving factors and challenges in the global dry eye syndrome market?
  • What is the structure of the global dry eye syndrome market and who are the key players?
  • What is the degree of competition in the global dry eye syndrome market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Akorn Inc.
  • Alimera Science
  • Allergan plc.
  • Auven Therapeutics
  • Bausch + Lomb
  • GlaxoSmithKline plc.
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Properties
4.3 Key Industry Trends

5 Global Dry Eye Syndrome Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Disease Type
5.4 Market Breakup by Drug Type
5.5 Market Breakup by Product
5.6 Market Breakup by Distribution Channels
5.7 Market Breakup by Region
5.8 Market Forecast

6 Market Breakup by Disease Type
6.1 Evaporative Dry Eye Syndrome
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aqueous Dry Eye Syndrome
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Drug Type
7.1 Lubricant Eye Drops
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Anti-inflammatory Drugs
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Autologous Serum Eye Drops
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Product
8.1 Liquid Drops
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Gel
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Liquid Wipes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Eye Ointment
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast

11 Global Dry Eye Syndrome Industry: SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Global Dry Eye Syndrome Industry: Value Chain Analysis

13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Global Dry Eye Syndrome Industry: Price Analysis
14.1 Price Indicators
14.2 Price Structure
14.3 Margin Analysis

15 Manufacturing Process
15.1 Product Overview
15.2 Raw Material Requirements
15.3 Manufacturing Process
15.4 Key Success and Risk Factors

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Novartis AG
16.3.2 Allergan plc.
16.3.3 Otsuka Holdings Co., Ltd.
16.3.4 Santen Pharmaceutical Co., Ltd.
16.3.5 Nicox S.A.
16.3.6 Auven Therapeutics
16.3.7 Akorn, Inc.
16.3.8 Bausch + Lomb
16.3.9 Alimera Science
16.3.10 GlaxoSmithKline plc
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Novartis AG
  • Allergan plc.
  • Otsuka Holdings Co. Ltd.
  • Santen Pharmaceutical Co. Ltd.
  • Nicox S.A.
  • Auven Therapeutics
  • Akorn Inc.
  • Bausch + Lomb
  • Alimera Science
  • GlaxoSmithKline plc.
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4752352
Adroll
adroll